2023
DOI: 10.1021/acschembio.3c00475
|View full text |Cite
|
Sign up to set email alerts
|

One-Step Selective Labeling of Native Cell Surface Sialoglycans by Exogenous α2,8-Sialylation

Jonathan L. Babulic,
Joshua M. Kofsky,
Marie E. Boddington
et al.

Abstract: Exo-enzymatic glycan labeling strategies have emerged as versatile tools for efficient and selective installation of terminal glyco-motifs onto live cell surfaces. Through employing specific enzymes and nucleotide-sugar probes, cells can be equipped with defined glyco-epitopes for modulating cell function or selective visualization and enrichment of glycoconjugates. Here, we identifyCampylobacter jejunisialyltransferase Cst-II I53S as a tool for cell surface glycan modification, expanding the exo-enzymatic lab… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 84 publications
1
0
0
Order By: Relevance
“…As B3GNT2 requires LacNAc as the acceptor substrate and is reported to act on glycolipids in addition to glycoproteins, it is feasible that B3GNT2 may also be acting on glycolipid substrates. However, glycolipids may not be extended far enough from the cell surface to be accessible for B3GNT2 transfer, analogous to what has been suggested for sialyltransferases that did not exo-enzymatically label cellular glycolipids despite having reported glycolipid substrate activity . Overall, our data suggest that the apparent glycan subclass specificity of glycosyltransferases employed in exo-enzymatic glycan editing is dependent on the cell line used, a factor that should be considered when reporting enzyme specificity.…”
Section: Resultssupporting
confidence: 62%
“…As B3GNT2 requires LacNAc as the acceptor substrate and is reported to act on glycolipids in addition to glycoproteins, it is feasible that B3GNT2 may also be acting on glycolipid substrates. However, glycolipids may not be extended far enough from the cell surface to be accessible for B3GNT2 transfer, analogous to what has been suggested for sialyltransferases that did not exo-enzymatically label cellular glycolipids despite having reported glycolipid substrate activity . Overall, our data suggest that the apparent glycan subclass specificity of glycosyltransferases employed in exo-enzymatic glycan editing is dependent on the cell line used, a factor that should be considered when reporting enzyme specificity.…”
Section: Resultssupporting
confidence: 62%